1. Home
  2. BCYC vs HDSN Comparison

BCYC vs HDSN Comparison

Compare BCYC & HDSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • HDSN
  • Stock Information
  • Founded
  • BCYC 2009
  • HDSN 1991
  • Country
  • BCYC United Kingdom
  • HDSN United States
  • Employees
  • BCYC N/A
  • HDSN N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • HDSN Industrial Specialties
  • Sector
  • BCYC Health Care
  • HDSN Consumer Discretionary
  • Exchange
  • BCYC Nasdaq
  • HDSN Nasdaq
  • Market Cap
  • BCYC 492.1M
  • HDSN 410.9M
  • IPO Year
  • BCYC 2019
  • HDSN 1994
  • Fundamental
  • Price
  • BCYC $6.92
  • HDSN $10.10
  • Analyst Decision
  • BCYC Buy
  • HDSN Buy
  • Analyst Count
  • BCYC 11
  • HDSN 4
  • Target Price
  • BCYC $22.91
  • HDSN $8.38
  • AVG Volume (30 Days)
  • BCYC 213.9K
  • HDSN 302.3K
  • Earning Date
  • BCYC 10-30-2025
  • HDSN 11-03-2025
  • Dividend Yield
  • BCYC N/A
  • HDSN N/A
  • EPS Growth
  • BCYC N/A
  • HDSN N/A
  • EPS
  • BCYC N/A
  • HDSN 0.40
  • Revenue
  • BCYC $19,281,000.00
  • HDSN $224,778,000.00
  • Revenue This Year
  • BCYC N/A
  • HDSN $3.02
  • Revenue Next Year
  • BCYC N/A
  • HDSN $8.53
  • P/E Ratio
  • BCYC N/A
  • HDSN $25.73
  • Revenue Growth
  • BCYC N/A
  • HDSN N/A
  • 52 Week Low
  • BCYC $6.10
  • HDSN $5.11
  • 52 Week High
  • BCYC $28.67
  • HDSN $10.52
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 41.28
  • HDSN 54.28
  • Support Level
  • BCYC $6.77
  • HDSN $10.06
  • Resistance Level
  • BCYC $7.32
  • HDSN $10.52
  • Average True Range (ATR)
  • BCYC 0.39
  • HDSN 0.26
  • MACD
  • BCYC 0.01
  • HDSN -0.05
  • Stochastic Oscillator
  • BCYC 19.04
  • HDSN 22.22

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About HDSN Hudson Technologies Inc.

Hudson Technologies Inc is an American industrial products manufacturer. It develops products which are mainly used in commercial air conditioning, industrial processing, and refrigeration systems. The company products include refrigerant and industrial gases, refrigerant management services and RefrigerantSide services, which consist of system decontamination. These are performed at customer's site using its Zugibeast system, which is a fast and portable system and allows the R-Side services team to accelerate critical services while saving customers time, money and aggravation. The company also owns a web-based real-time monitoring service which is used in the facility's refrigeration systems and other energy systems.

Share on Social Networks: